In HCC, CXCL9 is associated with the recruitment of tumor-infiltrating immune cells (mainly CD4+ and CD8+ lymphocytes) shaping the TME and possibly amplifying anti-tumor responses of cytotoxic T cells [31]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.